Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Rat Model Market Poised To Hit $2.8 Billion By 2030 With A 9.9% CAGR
The rat model market has experienced robust expansion over recent years. This market is projected to expand from $1.75 billion in 2025 to $1.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this growth stemmed from factors such as the rise in biomedical research activities, the greater adoption of animal models for drug discovery, the expansion of academic research institutions, the accessibility of diverse rat strains including both inbred and outbred varieties, and the escalating demand for toxicology testing requirements.
The rat model market is anticipated to experience significant expansion in the upcoming years. It is predicted to reach $2.8 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This growth throughout the forecast period can be attributed to increased investment in precision medicine research, a rising demand for predictive disease models, the broadening of gene-editing applications, a greater emphasis on lowering clinical trial failure rates, and the increased adoption of humanized rat platforms. Prominent trends expected in the forecast period encompass the growing utilization of CRISPR-based rat models, an escalating demand for immunodeficient and humanized rats, the increasing integration of preclinical disease modeling, the expansion of genetic editing technologies, and a heightened focus on the accuracy of translational research.
Get A Free Sample Report With In-Depth Market Insights:
Rat Model Market Growth Catalysts And Demand Drivers
The increasing need for pharmaceutical products is anticipated to drive the expansion of the rat model market in the foreseeable future. Researchers utilize rat models for drug discovery due to their manageable feeding requirements and smaller stature compared to more intricate mammals like primates, making them a more practical choice. Consequently, the growing demand for medicines directly fuels the demand for the rat models market. As an illustration, data from July 2024, provided by the National Center for Biotechnology Information, a US-based government agency, revealed that total medicine expenditure in the United States in 2023 saw a 13.6% rise over 2022, amounting to $722.5 billion. Hence, the heightened demand for medicines is serving as a primary impetus for the rat model market.
Rat Model Market Segment Landscape: Which Areas Lead Development?
The rat model market covered in this report is segmented –
1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing
3) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications
Subsegments:
1) By Knockout: CRISPR Knockout, Traditional Knockout
2) By Outbred: Sprague Dawley, Long-Evans, Wistar
3) By Inbred: Fischer 344, Lewis, Buffalo
4) By Hybrid: F1 Hybrid, F2 Hybrid
5) By Immunodeficient: Nude Rats, SCID Rats
6) By Conditioned: Obese Rats, Diabetic Rats
Rat Model Market Trends Shaping Long-Term Demand
Major companies and preclinical research organizations are increasingly concentrating on the development of specialized animal models for nephropathy. These models are crucial for better mimicking human kidney diseases and expediting the discovery of new therapies. Nephropathy animal models refer to animals that have been engineered or induced to reproduce human kidney diseases, offering a controlled system for investigating disease mechanisms, testing treatments, and exploring renal dysfunction, injury, and treatment responses. For instance, in October 2024, Physiogenex, a France-based preclinical research company, unveiled its new IgA nephropathy rat model, which it had previously presented at ASN Kidney Week. This model is designed to provide researchers with a reliable platform for translational studies, exhibiting hallmark characteristics of IgA nephropathy, including mesangial IgA deposition and proteinuria, thereby supporting the development of targeted therapies and advancing mechanistic research in kidney disease.
Rat Model Market Leading Players And Competitive Positioning
Major companies operating in the rat model market are Genoway SA, Charles River Laboratories International Inc, Taconic Biosciences Inc, Envigo Ltd, Janvier Labs, Harlan Laboratories Inc, Cyagen Biosciences Inc, Ozgene Pty Ltd, Beijing Biocytogen Co Ltd, Ingenious Targeting Laboratory, Mirimus Inc, Pharmaron Beijing Co Ltd, PolyGene AG, Shanghai Model Organisms Center Inc, Transgenic Inc, Viva Biotech Holdings, WuXi AppTec Co Ltd, Applied StemCell Inc, Transviragen Inc, Biomere, Laboratory Corporation of America Holdings, Horizon Discovery Group PLC, Synthego Corporation, ViGene Biosciences Inc
View The Full Rat Model Market Report:
Rat Model Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the rat model market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
